All In Biotech

Drug Trial Radar · NCT00485940

Efficacy and Safety Study of Prucalopride for the Treatment of Patients With Chronic Constipation

A Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of R108512 Tablets in Subjects With Chronic Constipation

Last checked: Nov 20, 2026Latest source record: Sep 25, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 641 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

641

Actual

Start

Mar 1998

Primary completion

May 1999

Study completion May 1999

Sponsor

Lead sponsor
MovetisIndustry
Sponsor type
Industry
First posted
Jun 13, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether prucalopride is safe and effective in the treatment of chronic constipation Hypothesis: Prucalopride 2 mg and 4 mg given once daily for 12 weeks is superior to placebo for the treatment of patients with chronic constipation and is well tolerated in those patients

Conditions

  • Constipation

Interventions

  • PrucaloprideDrug

    2 mg o.d.

  • PlaceboOther

    Placebo o.d.

  • PrucaloprideDrug

    4 mg o.d.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of subjects with an average of 3 or more SCBM per weekTime frame: 12 weeks

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.